Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 April 2019 | Story Rulanzen Martin | Photo Rulanzen Martin
The Wolves
The Wolves is a play which does not conform to mainstream female stereotypes.

It is the perfect father and daughter team - Gerben Kamper, well-known actor and former drama lecturer at the University of the Free State (UFS), and his daughter Marijda Kamper, a current Drama and Theatre Arts staff member at UFS who have taken on the task of directing and producing the play, The Wolves by Sarah DeLappe.

It was a finalist for the Pulitzer Prize for Drama in 2017. “The text is regarded very highly, most drama texts do not normally get such recognition,” said Marijda.  

The play will be performed at the Scaena on the Bloemfontein Campus from Wednesday 10 April 2019.

“This play provides an excellent acting opportunity for our students. It is also nice to get a play which accommodates so many female actors,” said Marijda. Because this play digs deep within the daily struggles of being a girl, it is a sort of homage to the current #MeToo movement. It is a play about the coming-of-age for nine girls and centres in a non-stereotypical manner on the experiences, attitudes, anxiety and the adolescent hormonal changes of girls in the contemporary world. 

“It is very exciting to be back at the department. Especially with this play. It is very different from the usual plays we get. As it is set on an indoor soccer field, it is quite a different ballgame. This play provides the opportunity to focus on all the facets of acting,” said Gerben. 

The play has six scenes and takes place just before the start of a soccer match. “So the girls are busy with warm-up exercises just minutes before the whistle,” said Marijda. “The soccer unit at KovsieSport helped us a lot. They arranged a real soccer coach to assist us, and for two weeks she trained our girls like real soccer players.”



News Archive

UFS receives R3,284 million to research biosafety of genetically modified crops
2009-03-17

A testing facility at the University of the Free State (UFS), which is the only one of its kind in South Africa and a leader in its field in Africa, has received a grant of R3,284 million from the South African National Biodiversity Institute (SANBI) to do research on the biosafety of genetically modified crops in South Africa.

Prof. Chris Viljoen of the Genetically Modified Organisms (GMO) Testing Facility at the UFS says the grant forms part of a collaborative agreement between South Africa and Norway on the biosafety of GMOs.

The grant also makes provision for two M.Sc. bursaries as well as a regional biosafety workshop.

The research will focus on gene flow between genetically modified (GM) maize and non-GM maize and the potential impact thereof on the development of insect resistance.

Prof. Viljoen, who is head of Human Molecular Biology in the Department of Haematology and Cell Biology, says it is an honour to be selected to take part in the project and is groundbreaking in terms of GM maize on the environment. The project was initiated in 2009 and will run until the end of 2010.

The multi-institutional research include partners from the UFS, research groups from the University of North-West, the University of Fort Hare as well as SANBI and GenØk, the Norwegian centre for Gene Ecology. The GMO Testing Facility at the UFS was established in 2003 to perform routine GM detection for grain and food products in South Africa. The activities also include research into GM detection and biosafety of GM crops.

Media Release
Issued by: Lacea Loader
Assistant Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za
17 March 2009
 
 
Prof. Chris Viljoen of the Genetically Modified Organisms (GMO) Testing Facility at the UFS.
Photo: Supplied

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept